DelveInsight’s Hodgkin’s lymphoma (HL) - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Hodgkin’s lymphoma (HL) for the seven major markets i.e. United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Hodgkin’s lymphoma (HL) forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Hodgkin’s lymphoma (HL) till 2023.
Key Coverage and Benefits
• The report will help in developing business strategies by understanding the trends shaping and driving the global Hodgkin’s lymphoma (HL) market.
• Identifying patient populations in the global Hodgkin’s lymphoma (HL) market to improve product design, pricing, and launch plans.
• Organize sales and marketing efforts by identifying the best opportunities for Hodgkin’s lymphoma (HL) therapeutics in each of the markets covered.
• To understand the future market competition in the global Hodgkin’s lymphoma (HL) therapeutics market and Insightful review of the key market drivers and barriers.
Scope
• Report covers the disease overview including etiology, path physiology, symptoms, diagnosis, disease management, and current treatment options.
• Marketed information including available prescription drugs, its patent and exclusivity details followed by drug sales till 2023.
• The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5, Japan and rest of the word from 2013-2023.
• It also provides Hodgkin’s lymphoma (HL) for United States, EU5 and Japan from 2013 and forecasted Market to 2023.
Note: This report requires 7-10 business days to complete.
'
Table of Contents
• Hodgkin’s lymphoma (HL) overview
• Pathophysiology
• Symptoms of disease
• Etiology of disease
• Diagnosis of disease
• Treatment of disease
• Overview of Marketed drugs
• Drug Description
• Mechanism of Action
• Pharmacokinetics Properties
• Marketed Details
• Patent Information
• Patent Exclusivity Expiry Assessment United States (US)
• Patents Details
• Historical and Forecasted sales of marketed molecules in the Global Hodgkin’s lymphoma (HL) Market
• Global Epidemiology of Hodgkin’s lymphoma (HL) Forecasted to 2023
• Global Market (2013-2015)
• Global Forecasted Market (2016-2023)
• Global Market by Geography
• Market of US (2013-2015)
• Forecasted Market of US (2016-2023)
• Market of Europe
• Market of Germany (2013-2015)
• Forecasted Market of Germany (2016-2023)
• Market of United Kingdom (2013-2015)
• Forecasted Market of United Kingdom (2016-2023)
• Market of France (2013-2015)
• Forecasted Market of France (2016-2023)
• Market of Italy (2013-2015)
• Forecasted Market of Italy (2016-2023)
• Market of Spain (2013-2015)
• Forecasted Market of Spain (2016-2023)
• Market of Japan (2013-2015)
• Forecasted Market of Japan (2016-2023)
• Market of ROW (2013-2015)
• Forecasted Market of ROW (2016-2023)
• Appendix
• Report Methodology
• Consulting Services
• Disclaimer
• Report Purchase Options
• About DelveInsight
List of Tables
• Table 1: Drug Description
• Table 2: Drug, Marketed Details United States (US)
• Table 3: Drug, Patent Number Specific Patent Expiry in US (Year), 2015
• Table 4: Drug, Patent Details for US
• Table 5: Hodgkin’s lymphoma (HL) Drug Sales (USD Millions)
• Table 6: Global Epidemiology of Hodgkin’s lymphoma (HL) (2013-2023)
• Table 7: Hodgkin’s lymphoma (HL) Global Market (USD Millions), (2013-2015)
• Table 8: Hodgkin’s lymphoma (HL) Global Market (USD Millions), (2016-2023)
• Table 9: Hodgkin’s lymphoma (HL) US Market (USD Millions), (2013-2015)
• Table 10: Hodgkin’s lymphoma (HL) US Market (USD Millions), (2016-2023)
• Table 11: Hodgkin’s lymphoma (HL) Germany Market (USD Millions), (2013-2015)
• Table 12: Hodgkin’s lymphoma (HL) Germany Market (USD Millions), (2016-2023)
• Table 13: Hodgkin’s lymphoma (HL) United Kingdom Market (USD Millions), (2013-2015)
• Table 14: Hodgkin’s lymphoma (HL) United Kingdom Market (USD Millions), (2016-2023)
• Table 15: Hodgkin’s lymphoma (HL) France Market (USD Millions), (2013-2015)
• Table 16: Hodgkin’s lymphoma (HL) France Market (USD Millions), (2016-2023)
• Table 17: Hodgkin’s lymphoma (HL) Italy Market (USD Millions), (2013-2015)
• Table 18: Hodgkin’s lymphoma (HL) Italy Market (USD Millions), (2016-2023)
• Table 19: Hodgkin’s lymphoma (HL) Spain Market (USD Millions), (2013-2015)
• Table 20: Hodgkin’s lymphoma (HL) Spain Market (USD Millions), (2016-2023)
• Table 21: Hodgkin’s lymphoma (HL) Japan Market (USD Millions), (2013-2015)
• Table 22: Hodgkin’s lymphoma (HL) Japan Market (USD Millions), (2016-2023)
• Table 23: Hodgkin’s lymphoma (HL) ROW Market (USD Millions), (2013-2015)
• Table 24: Hodgkin’s lymphoma (HL) ROW Market (USD Millions), (2016-2023)
List of Figures
• Figure 1: Hodgkin’s lymphoma (HL) Drug Sales (USD Millions)
• Figure 2: Global Epidemiology of Hodgkin’s lymphoma (HL) (2013-2023)
• Figure 3: Hodgkin’s lymphoma (HL) Global Market (USD Millions), (2013-2015)
• Figure 4: Hodgkin’s lymphoma (HL) Global Market (USD Millions), (2016-2023)
• Figure 5: Hodgkin’s lymphoma (HL) US Market (USD Millions), (2013-2015)
• Figure 6: Hodgkin’s lymphoma (HL) US Market (USD Millions), (2016-2023)
• Figure 7: Hodgkin’s lymphoma (HL) Germany Market (USD Millions), (2013-2015)
• Figure 8: Hodgkin’s lymphoma (HL) Germany Market (USD Millions), (2016-2023)
• Figure 9: Hodgkin’s lymphoma (HL) United Kingdom Market (USD Millions), (2013-2015)
• Figure 10: Hodgkin’s lymphoma (HL) United Kingdom Market (USD Millions), (2016-2023)
• Figure 11: Hodgkin’s lymphoma (HL) France Market (USD Millions), (2013-2015)
• Figure 12: Hodgkin’s lymphoma (HL) France Market (USD Millions), (2016-2023)
• Figure 13: Hodgkin’s lymphoma (HL) Italy Market (USD Millions), (2013-2015)
• Figure 14: Hodgkin’s lymphoma (HL) Italy Market (USD Millions), (2016-2023)
• Figure 15: Hodgkin’s lymphoma (HL) Spain Market (USD Millions), (2013-2015)
• Figure 16: Hodgkin’s lymphoma (HL) Spain Market (USD Millions), (2016-2023)
• Figure 17: Hodgkin’s lymphoma (HL) Japan Market (USD Millions), (2013-2015)
• Figure 18: Hodgkin’s lymphoma (HL) Japan Market (USD Millions), (2015-2023)
• Figure 19: Hodgkin’s lymphoma (HL) ROW Market (USD Millions), (2013-2015)
• Figure 20: Hodgkin’s lymphoma (HL) ROW Market (USD Millions), (2016-2023)
• Takeda Pharmaceutical Company Limited
• Seattle Genetics Inc.
• Celgene Corporation
• Novartis AG
• Bristol-Myers Squibb Company
• Merck & Co. Inc.
• F. Hoffmann-La Roche Ltd.
• Sanofi
• Amgen Inc.
• AbbVie Inc.
